Use of ipsc systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic alzheimer's disease

Ended Project Grant Awarded Last action

Award ID
R01AG061894
Recipient
Awarding agency
Obligated
$6,750,418

Award facts

Assistance listing
93.866 Aging Research
Completion date
Originally
Funding
  • $5,873,172.03 Federal
  • $877,246.00 Non-federal
Place of performance
New York, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$32,052 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $877,246 $0
Amendment $877,246 $0
Amendment $877,246 $0
Amendment $877,246 $877,246
Amendment $877,246 $0
Amendment $877,246 $0
Original award $641,748 $0
Show all 11

Quick answers

Who received award R01AG061894?

R01AG061894 was awarded to New York Stem Cell Foundation Inc. by National Institute on Aging (National Institutes of Health) on September 30, 2018.

How much is award R01AG061894 worth?

$6,750,418 has been obligated on R01AG061894: $5,873,172 in federal funding and $877,246 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award